Astrocytoma type II

Search Trials
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Status:
Completed
Last Changed:
Jun 28, 2018
First Changed:
Nov 17, 2006
Disease(s):
Brain and Central Nervous System Tumors
Intervention(s):
imatinib mesylatepharmacological studyconventional surgery
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Status:
Completed
Last Changed:
Jul 31, 2020
First Changed:
Jul 31, 2007
Disease(s):
Brain and Central Nervous System Tumors
Intervention(s):
Erlotinib + Sirolimus
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Status:
Completed
Last Changed:
Feb 29, 2016
First Changed:
Jul 11, 2007
Disease(s):
Brain and Central Nervous System Tumors
Intervention(s):
temozolomideprotein expression analysisreverse transcriptase-polymerase chain reactiondiagnostic laboratory biomarker analysisimmunoenzyme technique
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
Status:
Completed
Last Changed:
Feb 27, 2019
First Changed:
Jan 13, 2006
Disease(s):
Brain and Central Nervous System Tumors
Intervention(s):
fluorine F 18 fluorothymidinepositron emission tomography
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
Status:
Completed
Last Changed:
Apr 5, 2013
First Changed:
Jan 27, 2003
Disease(s):
Brain and Central Nervous System Tumors
Intervention(s):
aldesleukinautologous tumor cell vaccinemuromonab-CD3sargramostimtherapeutic autologous lymphocytessurgical procedureradiation therapy

Connect. Empower. Inspire.